Evidence map›Paper›PMID 39724372›Full record

ArticleJAMA network open2024

Suicide Risk Among Veterans Who Receive Evidence-Based Therapy for Posttraumatic Stress Disorder.

Kevin G Saulnier, Stuart Brabbs, Benjamin R Szymanski, Ilan Harpaz-Rotem, John F McCarthy, Rebecca K Sripada

Registry-linked trialAbstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05220137 (Using the Multiphase Optimization Strategy to Adapt Cognitive Processing Therapy), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05220137 nacompletednot on this map

Using the Multiphase Optimization Strategy to Adapt Cognitive Processing Therapy

TypeinterventionalSponsorVA Office of Research and DevelopmentRan2022 to 2026Enrolled271ConditionsStress Disorders, Post-TraumaticArmsModified A-B-C: Working with Events, Thoughts, and Feelings, Challenging Questions, Patterns of Problematic Thinking, Challenging Beliefs, Veteran's choice of Module (Safety/Trust/Power and Control/Esteem/Intimacy)
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kevin G SaulnierSerious Mental Illness Treatment Resource and Evaluation Center, Office of Mental Health, Department of Veterans Affairs, Ann Arbor, Michigan.
Stuart BrabbsSerious Mental Illness Treatment Resource and Evaluation Center, Office of Mental Health, Department of Veterans Affairs, Ann Arbor, Michigan.
Benjamin R SzymanskiSerious Mental Illness Treatment Resource and Evaluation Center, Office of Mental Health, Department of Veterans Affairs, Ann Arbor, Michigan.
Ilan Harpaz-RotemVeterans Affairs Northeast Program Evaluation Center, West Haven, Connecticut.
John F McCarthySerious Mental Illness Treatment Resource and Evaluation Center, Office of Mental Health, Department of Veterans Affairs, Ann Arbor, Michigan.
Rebecca K SripadaSerious Mental Illness Treatment Resource and Evaluation Center, Office of Mental Health, Department of Veterans Affairs, Ann Arbor, Michigan.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Importance: Suicide rates are increased for veterans with posttraumatic stress disorder (PTSD). To inform Veterans Health Administration (VHA) operations, it is important to assess whether suicide risk for veterans differs by receipt of evidence-based treatments. Objective: To assess suicide risks among veterans in VHA care with new PTSD diagnoses who initiated or received an adequate course of evidence-based psychotherapy (cognitive processing therapy or prolonged exposure [CPT/PE]). Design, Setting, and Participants: This cohort study of veterans in VHA care evaluated suicide risk through 2020 for veterans with initial PTSD diagnoses during 2016-2019. Data collection and analyses were performed from March 22 to November 22, 2023. The population consisted of veterans who received an initial PTSD diagnosis (preceded by at least 12 months without a PTSD diagnosis) in 2016-2019. Exposures: Following the index PTSD diagnosis, receipt of a CPT/PE encounter and receipt of an adequate course of therapy (≥8 CPT/PE encounters). Main Outcome and Measure: Suicide mortality, per death certificate data from the Veterans Affairs/Department of Defense Mortality Data Repository. Results: Of the population-based sample of 847 217 US veterans, most were male (735 974 [86.9%]); the mean (SD) age was 50.1 (16.3) years. From initial PTSD diagnosis through 2020, there were 1552 suicides. Multivariable proportional hazards regression indicated that initiation of CPT/PE treatment was associated with a 23% lower suicide risk compared with those who did not initiate CPT/PE (hazard ratio [HR], 0.77; 95% CI, 0.59-0.99). Receipt of an adequate course was not associated with suicide (HR, 0.80; 95% CI, 0.55-1.18). Similar results were observed when limiting the cohort to those who received any psychotherapy (n = 552 742; CPT/PE initiation: HR, 0.73; 95% CI, 0.56-0.95; adequate course: HR, 0.77; 95% CI, 0.52-1.12). Conclusions and Relevance: The findings of this study suggest that, among veterans in VHA care with new PTSD diagnoses, CPT/PE initiation was associated with lower suicide risk. However, for those who initiated CPT/PE, receipt of 8 or more sessions was not associated with added benefit.

Indexed as

Stress Disorders, Post-TraumaticSuicideVeteransAdultAgedCognitive Behavioral TherapyCohort StudiesFemaleHumansMaleMiddle AgedRisk FactorsUnited StatesUnited States Department of Veterans Affairs

Identifiers

PMID39724372
PMCPMC11672158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.